NCT05227222 is a NA clinical trial of PEP-device in Swimming Induced Pulmonary Edema (SIPE), sponsored by Dalarna County Council, Sweden.

Who is sponsoring NCT05227222?

NCT05227222 is sponsored by Dalarna County Council, Sweden.

What drugs are being tested in NCT05227222?

Interventions in NCT05227222: PEP-device.

What condition does NCT05227222 study?

NCT05227222 studies Swimming Induced Pulmonary Edema (SIPE), Pulmonary Edema, Lung Diseases.

Is NCT05227222 still recruiting?

NCT05227222 is currently recruiting now. Last updated 27 February 2025.

Last reviewed 2025-02-27 · How we verify

NCT05227222

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

PEP-device for Treatment of Swimming-induced Pulmonary Edema (SIPE)

Recruiting now NA Last updated 27 February 2025

What this trial tests

NA trial testing PEP-device in Swimming Induced Pulmonary Edema (SIPE) in 40 participants. Currently enrolling.

Timeline

2 July 2022

Primary endpoint
15 July 2027

15 July 2027

Quick facts

Lead sponsor	Dalarna County Council, Sweden
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	40
Start date	2 July 2022
Primary completion	15 July 2027
Estimated completion	15 July 2027
Sites	1 location across Sweden

Drugs / interventions tested

PEP-device

Conditions studied

Swimming Induced Pulmonary Edema (SIPE) — all drugs for Swimming Induced Pulmonary Edema (SIPE) →
Pulmonary Edema — all drugs for Pulmonary Edema →
Lung Diseases — all drugs for Lung Diseases →

Sponsor

Dalarna County Council, Sweden

Who can join

18 and older, any sex, with Swimming Induced Pulmonary Edema (SIPE) or Pulmonary Edema. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In swimming induced pulmonary edema (SIPE), there is a lack of knowledge regarding optimal treatment. The present study was designed to assess the benefit of treatment with positive expiratory pressure device (PEP-device) compared to spontaneous recovery in patients with SIPE without hypoxia in the out-of-hospital environment.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Swimming Induced Pulmonary Edema (SIPE)

Currently open trials in the same condition.

NCT04307615 — O2 Versus CPAP Treatment of Patients Undergoing SIPE Therapy (OCTOPUS) · NA · recruiting

Other Dalarna County Council, Sweden trials

Trials by the same sponsor.

NCT07586033 — Prevalence and Functional Impact of Hand and Wrist Symptoms in Ice Hockey Players · not yet recruiting
NCT07115160 — The Leksand Hockey Trial on Grip Strength · NA · recruiting
NCT06984120 — Increased Extravascular Lung Water in Asymptomatic Open-water Swimmers · completed
NCT05923762 — Oral Health Related Quality of Life · unknown
NCT05296941 — Oral Cancer Screening for Early Detection of Premalignant Disorders (PMOD) · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05227222 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Dalarna County Council, Sweden
Last refreshed: 27 February 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05227222.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing